Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net income (loss)	$ (2,548,725)	$ 1,940,963
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization – continuing operations	574,672	556,300
Depreciation and amortization – discontinued operations	37,992	49,496
Amortization of debt issuance costs	250,000	587,750
Share-based compensation		33,938
Amortization of prepaid share-based compensation		111,000
Gain on forgiveness of earnout		(6,100,000)
Changes in assets and liabilities:
Accounts receivable	978,029	(419,007)
Inventories	1,852,604	809,084
Prepaid expenses and other current assets	254,118	56,933
Accounts payable	(450,667)	(301,222)
Accrued expenses and other current liabilities	180,856	2,138,574
Discontinued operations	(129,055)	(187,101)
Net cash provided by (used in) operating activities	999,824	(723,292)
Cash flows from investing activities:
Purchases of property and equipment – continuing operations	(157)
Purchases of property and equipment – discontinued operations	(44,490)
Net cash used in investing activities	(44,647)
Cash flows from financing activities:
Net proceeds from issuance of common stock		710,000
Net (repayments) borrowings under line of credit	(600,000)	575,000
Net cash used in financing activities	(759,937)	(3,715,767)
Net decrease in cash and cash equivalents	(195,240)	(4,439,059)
Cash and cash equivalents, beginning of the period	239,187	5,247,836
Cash and cash equivalents, end of the period	434,427	808,777
Supplemental disclosure of cash flow information:
Cash paid for interest	375,637	268,500
Cash paid for income taxes
Issuance of common stock to line of credit holders		60,000
Issuance of common stock to vendors for future services		387,000
Issuance of common stock to employees and directors for settlement of liabilities		262,916
Issuance of common stock to vendors for settlement of liabilities	143,201	105,693
Issuance of common stock to noteholders for settlement of accrued interest		1,148,000
Issuance of common stock to noteholders for settlement of cash warrant liabilities		206,779
Forgiveness of interest – related parties		3,006,896
Convertible shares under notes payable		99,199
Nonrelated Party [Member]
Cash flows from financing activities:
Repayments under convertible notes payable		(4,915,000)
Related Party [Member]
Cash flows from financing activities:
Repayments under convertible notes payable	$ (159,937)	$ (85,767)